Strong Growth, Broken Operating Leverage
Revenue surged 27.6% YoY, but sequential profit fell 15.9% despite only -3% revenue decline. Management reaffirmed guidance despite 14.9% organic growth—a signal that wage headwinds and FX benefits are about to reverse.
The quarterly result splits into two stories. On the tape, Sagility delivered ₹1,964 Cr revenue (+27.6% YoY) and ₹217 Cr net profit (+45.9% YoY), numbers that support the bull case for India-focused healthcare outsourcing. The adjusted PAT of ₹270 Cr (+35.1% YoY) sits on a solid 13.7% margin. But the quarter-over-quarter picture is where the real tension surfaces: profit fell 15.9% despite revenue declining only 3%. That spread—a 12.9 percentage-point gap between revenue decline and profit decline—signals the operating model is under stress. And management's decision to reaffirm full-year guidance rather than raise it, despite 14.9% constant-currency organic growth, is the clearest signal that leadership sees the headwinds coming.
₹216.8 Cr
+45.9% YoY
₹270 Cr
+35.1% YoY, 13.7% margin
-15.9%
vs -3% revenue
24%
-90 bps QoQ, within 24-25% FY27 guidance
Where the profit gap came from
The ₹53 Cr gap between adjusted PAT (₹270 Cr) and reported PAT (₹217 Cr) is largely driven by a one-time minimum wage gratuity and absence accrual charge of ₹15.1 Cr. This is a disclosure item—management separated it out, so adjusted profit is the right lens to use for run-rate evaluation. But more important than the one-time is the sequential direction: in a quarter with seasonal headwinds (Open Enrolment revenue of $24.8 million rolled off), the margin compression was exacerbated by two factors that management flagged. First, the minimum wage impact was only 40 basis points in Q1 because the wage hike took effect partway through the quarter; the full 120 basis-point headwind for FY-2027 is still to come. Second, the FX tailwind of 100+ basis points that boosted Q1 EBITDA margins came from rupee depreciation and favorable hedge timing, but hedges were taken at much lower rates—that benefit will reverse.
The increase in minimum wages in Karnataka was pretty significant, and so absorbing this reflects the strength and flexibility of our operating model.
Management's key claims vs. what holds up
Revenue growth of 27.6% YoY and 15.2% constant currency validates market position
Delivered ₹1,964 Cr, exact 27.6% YoY, 14.9% const curr organic (ex-CareSeed)
Supported
Adjusted EBITDA margin of 24% maintained despite 120 bps minimum wage headwind
Q1 at 24%, but only 40 bps wage impact hit (one month only); 100+ bps FX benefit offset. Full 120 bps impact ahead.
Supported, but conditional on FX
Sequential organic revenue growth 5.1% after removing seasonal revenue
Steady-state revenue ex-seasonality confirms 5.1%, showing underlying momentum despite wage pressures
Supported
CareSeed acquisition adds 26 new mid-market clients with $5.1M CY25 revenue at 31.4% EBITDA
CareSeed had 30 clients, 4 common, so 26 net new confirmed; revenue and EBITDA figures match
Supported
Managed services conversations ongoing; deals remain 3–6 months out
No new managed service wins disclosed; strategic pivot depends on timelines not slipping
Supported; execution risk material
What changed on this call
CareSeed acquisition closed. The company added 26 net new mid-market clients with $5.1 million in CY25 revenue at a 31.4% EBITDA margin. Active client groups tripled to 109. This expands capabilities in HEDIS compliance and quality workflows—areas Sagility plans to cross-sell into its larger payer base. Minimum wage impact quantified. Previously implicit, management now explicitly flagged 120 basis points of full-year margin headwind in Karnataka and Telangana, where 65–70% of headcount sits. Mitigation via state expansion and efficiency gains will take 12–18 months. Attrition improved sharply. Quarterly attrition fell to 28.6% from 38.1% the prior quarter, a meaningful 930 basis-point improvement. The minimum wage hike may have helped stabilize talent retention, though the attrition rate still sits above prior-year Q1 levels. Managed services remain conversational. No new deal closes disclosed; strategic pivot still depends on multi-month sales cycles compressing and deals shipping. If timelines slip, growth model execution is at risk.
The bull-bear ledger
27.6% YoY revenue growth validates healthcare outsourcing demand thesis amid payer cost pressures
14.9% constant currency organic growth supports 'low double-digit' FY27 guidance midpoint
EBITDA margins maintained at 24% despite 40 bps wage impact shows operational flexibility
CareSeed adds capabilities and triples active client groups to 109, expanding mid-market footprint
Strong balance sheet (0.06x net debt-to-EBITDA) and cash conversion (70% EBITDA-to-cash) support M&A optionality
Attrition improved significantly QoQ; Great Place to Work ranking (11th in India) reflects talent strength
Sequential PAT fell 15.9% despite only -3% revenue decline—operating leverage reversing
120 bps minimum wage impact is recurring and structural, affecting 65–70% of headcount; only 40 bps hit Q1
FX tailwind of 100+ bps Q1 is non-repeatable; hedges taken at lower rates will reverse the benefit
Managed services (strategic pivot) still in 3–6 month conversations with zero new wins disclosed
Client concentration rising; top-4-5 cohort showing soft TTM growth; one major client migrating onshore→offshore
Stock down 25% from all-time high; market faded the result pop (-1.63% day 1, -3.39% by day 3)
Risks, ranked by holder severity
Operating leverage breakdown: QoQ PAT -15.9% on -3% revenue
HighSignals fixed costs (wages, infrastructure) are kicking in. If trend continues into Q2-Q3 as full wage impact hits, profit guidance will miss despite organic growth. Margin compression is real, not transient.
Minimum wage 120 bps FY27 recurring headwind
HighAffects 65–70% of headcount in Karnataka and Telangana. Only 40 bps hit Q1; full double impact comes Q2 onwards. Mitigation via state expansion and efficiency gains takes 12–18 months. No quick fixes.
FX tailwind reversal (100+ bps Q1 not repeatable)
MediumHedges were taken at lower rates; benefit is transient. Rupee strength or hedge expiry in Q2-Q3 will show the headwind. This masked 40–50 bps of real margin compression in Q1.
Deal timing risk on managed services pivot
MediumStrategic growth depends on outcome-based managed service deals moving from 3–6 month conversations to closes. Zero deals disclosed yet. If timelines slip to FY28, growth model stress tested.
Client concentration and volume deflation
MediumTop-3 client % rising; top-4-5 cohort TTM growth soft. One major client migrating work onshore→offshore (margin-accretive but revenue-reducing). Portfolio concentration risk if churn accelerates post-wage hike.
Attrition sustainability unclear post-wage hike
Low28.6% quarterly attrition is an improvement from 38.1%, but still above prior-year Q1. Wage hike may not be sufficient to keep talent if competing offers are attractive. Monitor Q2-Q3 for re-acceleration risk.
How the street is positioned
The market's post-result reaction was muted and negative, a strong signal that the street sees the headwinds too. The stock fell 1.63% on day 1 and continued to fade to -3.39% by day 3, suggesting initial optimism about the 27.6% revenue growth was quickly tempered by the margin and quarter-over-quarter dynamics. This is the market's own verdict: strong growth does not excuse the operating leverage reversal and guidance hold. The stock is now trading at ₹43.29, down 25% from its all-time high of ₹57.89. It sits above its 20-day and 50-day simple moving averages but remains below its 200-day SMA, suggesting the uptrend from the lows has stalled. RSI at 58.2 is neutral, and volume is normal—no panic, but no new buying conviction either. On the ownership front, FII holdings have trimmed to 10.02% from 10.25%, indicating foreign investors are reducing exposure. Domestic institutional investors are stepping in (22.29% from 21.36%), a classic signal of divergence: global money is cautious, domestic money is accumulating. Promoter holdings are flat at 50.95%, offering no new signal.
1 · Q2 FY27 adjusted EBITDA margin and PAT
The minimum wage impact will double (120 bps vs 40 bps Q1); FX hedges taken at lower rates will expire, reversing 100+ bps of Q1 benefit. If Q2 EBITDA margin stays above 23%, management's guidance hold is validated. If it slips to 22% or below, margin guidance will narrow and growth outlook will face real headwinds. This is the proof point for the operating model's resilience.
2 · Managed service deal closes and ACV traction (Q2–Q3 guidance updates)
Strategic pivot depends on converting 3–6 month conversations into wins. Management cited multiple active opportunities but disclosed zero Q1 closes. If Q2 and Q3 still show no new managed service contracts, the assumption that this model drives FY27 growth will be questioned. Need to see at least one signed deal by end-Q3 to keep execution thesis credible.
3 · CareSeed cross-sell pipeline and attrition trend (Q2 earnings)
Management noted 6–7 BroadPath opportunities in pipeline and bullish on CareSeed synergies. Monitor for ACV uplift, client consolidation, and retention. Attrition at 28.6% is improved but fragile—if it re-accelerates post-wage hike, it signals the wage increase was insufficient to stabilize talent costs. If client churn accelerates, organic growth momentum will erode.
Sagility India delivered a quarter that validates its market position but exposes the strain in its operating model. Revenue growth of 27.6% YoY and 14.9% constant currency organic growth are real and support the thesis that healthcare payers will continue to outsource amid cost pressures. But the sequential profit decline of 15.9% despite only -3% revenue fall is the quarter's honest story: wages and fixed costs are kicking in, and management knows it—hence the guidance hold, not raise.
For holders, the question is whether the company can stabilize margins at 24% or better despite the 120 basis-point wage headwind coming in Q2. For new money, the risk-reward is not compelling until that answer is clear. The number to track from here is adjusted EBITDA margin in Q2 and beyond—if it holds 23%+, the operating model is resilient; if it slips below 22%, execution risk is real. Management's confidence tone on the call was appropriate, but the guidance conservatism was the real message: they see the headwinds as substantial and lasting.
Rating: Hold (Confidence 6/10). Hold for existing shareholders pending Q2 margin visibility and managed service execution clarity. Pass for new money until the wage mitigation story is proven and at least one material managed service deal is signed. Fair value depends on resolving these near-term execution risks.
Record YoY growth, sequential softness from seasonal & wage pressure ahead
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Met prior quarter guidance; absorbing wage shock reflects operational strength. Cautious FY27 guidance on unproven managed services execution.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong YoY topline growth (27.6% revenue, 45.9% reported PAT) validates market positioning in healthcare outsourcing amid payer cost pressures. However, sequential PAT declined 15.9% despite only -3% revenue softness, signaling operating leverage breaking down as minimum wage impact (120 bps full-year) begins to bite. Management maintained but did not raise guidance despite 14.9% constant currency organic growth, suggesting they see headwinds (wage costs, FX hedges expiring, deal timing risk) offsetting near-term momentum.
₹1963.5 Cr
Revenue · +27.6% YoY₹216.8 Cr
Reported PAT · +45.9% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
Revenue growth of 27.6% YoY and 15.2% constant currency
METDelivered result confirms ₹1963.5 Cr with exact 27.6% YoY, organic 14.9% const curr
Adjusted EBITDA margin of 24%, growing 27.9% YoY
METDelivered OPM 21.6%; adjusted EBITDA 24% matches guidance range, excluding one-time wage charge
Adjusted PAT margin 13.7% and +35.1% YoY growth
OVERSTATEDDelivered reported PAT margin 11.0% (+45.9% YoY); adjusted excludes ₹151M wage exceptional charge
Maintained 24-25% EBITDA margin guidance despite 120 bps wage headwind
METQ1 at 24%; achieved via 100+ bps FX benefit offsetting 40 bps wage impact. Full-year 120 bps impact ahead.
Sequential organic revenue growth 5.1% after removing $24.8M seasonal open enrolment
METSteady-state revenue $197.3M → $207.3M = 5.07%; sequential reported -3.0% matches seasonality claim
CareSeed acquisition adds 26 new mid-market clients with $5.1M CY25 revenue, 31.4% EBITDA
METCareSeed had 30 clients; 4 common, so 26 new additions confirmed; revenue figures stated
Earnings quality
What changed since the last call
CareSeed acquisition closed; 26 clients added
NewStrengthens quality capabilities (HEDIS, Medicare Advantage) and mid-market footprint. $5.1M CY25 revenue at 31.4% EBITDA. Cross-sell upside with Sagility's platform.
Minimum wage impact quantified at 120 bps FY27
UpgradePrior guidance silent on this; now explicit headwind. 65-70% of headcount in Bangalore & Hyderabad exposed. Management says will mitigate via efficiency + state expansion.
Managed service deals remain conversational (3-6 months)
NeutralStrategic priority but timing uncertain. No specific contracts won yet. Upside if timelines compress; downside if deals slip to FY28.
Attrition improved sharply QoQ but remains above prior-year
Upgrade28.6% quarterly vs 38.1% Q4 (+/- seasonality); wage increase may stabilize talent retention. Monitoring needed post-hike.
The Q&A
Analysts pressed on growth sustainability given 14.9% const curr vs 'low double-digit' guidance and whether 5% sequential organic can repeat. Management held firm on guidance, emphasizing deal timing unpredictability. Skepticism on managed services materialization and whether margin guidance is overly conservative. No material pushback on business fundamentals; market believes in cost-pressure-driven payer outsourcing demand.
Min wage impact & mitigation — Akshat Agarwal, Jefferies
Answered65-70% headcount in K&T; 15-20% elsewhere (TN, Indore, Mumbai). Mitigating via state expansion & operational efficiency; full mitigation takes 12-18 months.
Sequential growth trajectory — Baidik Sarkar, Unifi Capital
Partial5% is not a baseline; broad-based growth across 15-20 clients min per qtr from existing clients + FY26 new adds. Mix still includes effort-based deals. Managed services take time, timing is constraint not capacity.
Top client cohort slowdown — Rohit Thorat, Axis Capital
AnsweredOne client in cohort moving large volume onshore → offshore; recurring work but margin accretive, revenue deflating. Not permanent.
Margin guidance headroom — Rohit Thorat, Axis Capital
AnsweredMin wage impact was only 1 month in Q1; full quarter impact ahead (double). Hedges at lower rates. Want visibility post-Q2 before narrowing range.
M&A pipeline & valuations — Vamshi Krishna, Kotak Securities
PartialNo specific timelines; depends on capabilities needed & market availability. Clinical, quality, care management, provider services, tech all of interest. RCM targets had high valuations, not pursued.
Seasonal revenue repeat — Sameer Pardikar, Elara Capital
PartialExpect similar 6% of total revenue from seasonality (vs 3% pre-BroadPath). Specifics not known until Sept when plans finalize their bids.
Client insourcing & AI deflation risk — Rishabh Mehra, Demeter Advisors
AnsweredInsourcing to US likely; offshoring to us is cost-saving, so unlikely. AI deflation is real expectation; Everest research shows 70% claim AI adoption but only 10% see measurable returns. We position as outcome-based partner committing to cost takeout via workflow redesign.
Guidance
FY27 low double-digit constant currency organic growth
HighQ1 achieved 14.9% const curr organic, within guidance range. Underpinned by cost pressures driving payer demand; 14-15% appears achievable midpoint.
Adjusted EBITDA margin 24-25% for FY27
MediumQ1 at 24% despite 40 bps min wage (only 1 month) via 100+ bps FX benefit. Full-year 120 bps wage impact + FX hedge expiry headwinds. Offset via efficiency initiatives & state expansion; upper end possible if FX holds.
Capex ~₹75 Cr/quarter (4-5% of revenue)
MediumQ1 capex ₹75 Cr for infrastructure; investment in tech, AI, automation capabilities ongoing. No specific FY27 capex guidance given.
Risks the call surfaced
Minimum wage impact
High120 bps FY27 impact in Karnataka & Telangana where 65-70% of headcount resides. Recurring. Cascading wage pressure beyond minimum wage also hitting margins. Estimated to take 12-18 months to fully mitigate.
Deal timing & managed services execution
MediumStrategic shift to outcome-based managed service deals central to guidance. Currently 3-6 month sales cycles in active conversations but no wins yet. Success depends on client capability to redesign workflows & Sagility's ability to commit cost targets.
Foreign exchange headwinds
MediumQ1 benefited from 100+ bps FX tailwind due to rupee depreciation & favorable hedge timing. Hedges taken at much lower rates; as benefit wears off in Q2-Q3, headwind reverses. Full-year guidance depends on FX rates holding.
Client concentration & volume deflation
MediumTop-3 client % growing; top-4-5 cohort showing soft TTM growth. One major client moving large work onshore→offshore (recurring but revenue-reducing). Suggests portfolio becoming more concentrated & subject to volume deflation.
AI deflation & market adoption uncertainty
MediumClients expect AI to deliver cost reductions but Everest research shows 70% adopted AI but only 10% achieved measurable improvements. Risk that failed implementations turn into deflation requests or insourcing attempts. Sagility's value prop is outcome-based commitment, but deal complexity/risk is high.
Management
Score 7/10. Clear, structured, specific on numbers but cautious on forward guidance. Transparent on headwinds (min wage, FX, deal timing). Avoided over-promising on managed services. Delivered on prior guidance; absorbed wage shock without cutting margins below guidance. Execution track record solid. CareSeed integrated quickly. Organic growth consistent with guidance.
1 · Q3 FY27
Open Enrolment season likely to drive seasonal revenue uplift matching prior year run-rate
2 · Q2 FY27 earnings
Full-quarter minimum wage impact and FX hedge expiry visible; management to narrow margin guidance
3 · FY27 (ongoing)
Managed service deals (3-6 month conversations) converting to wins; CareSeed cross-sell opportunities materializing
Management maintained but did not raise guidance despite 14.9% constant currency organic growth, suggesting they see headwinds (wage costs, FX hedges expiring, deal timing risk) offsetting near-term momentum.